• Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel
MIM™ software for theranostics

Make the promise of theranostics more attainable with vendor-neutral software that scales with your program and fits into your existing imaging environment.

Theranostics workflow
Connect the steps of the theranostics workflow from imaging to dosimetry
Support treatment decision-making, longitudinal evaluation, dosimetry and standardized molecular imaging workflows with tools designed for different stages of the theranostics pathway.
Treatment decision-making support
Turn quantitative imaging into actionable information
Use quantitative PSMA PET/CT and SPECT/CT information to assess whole-body disease burden and support treatment decision-making. Measures such as total tumor volume and SUVmean provide patient-specific information for review.
evolving-treatment-features-desktop-928x1016
Response assessment
Follow disease burden over time
Compare quantitative measurements across supported studies to assess changes in disease burden over time and support longitudinal evaluation of radiopharmaceutical therapy.
growing-patient-volumes-features-desktop-928x1016
Dosimetry
Support patient-specific dose evaluation
Move from quantitative reconstruction and segmentation through dose calculation and reporting with molecular radiotherapy dosimetry workflows designed to support single- and multiple-time-point approaches.
personalized-care-features-desktop-928x1016

MIM LesionID™ Pro

Extract quantitative patient-specific insights from PSMA PET/CT and SPECT/CT studies, aiding in assessing tumor burden during planning and evaluation of treatment options.

Treatment decision support

Quantify whole-body disease burden to support treatment decision-making.

Automated pre-processing

Automate pre-processing steps to reduce manual physician effort.

Lesion segmentation

Segment whole-body disease burden for quantitative review.

Tumor burden quantification

Calculate whole-body tumor volume and SUVmean for quantitative assessment.

MIM SurePlan™ MRT

Streamline theranostics dosimetry from quantitative reconstruction and segmentation through dose calculation and reporting.

Vendor-neutral recon

Zero-click reconstruction of SPECTs starts as soon as MIM receives your data.

Flexible dosimetry

Support single- and multiple-time-point dosimetry with validated methods.

Integrated reporting

Create reports for referring physicians and patients.

Simple segmentation

AI-based segmentation techniques.

MIM Encore™

Standardize molecular imaging workflows from image acquisition and reconstruction through processing, read preparation and interpretation.

Acquisition and recon

Automate supported image loading and reconstruction workflows.

Advanced image processing

Process images with guided MIM Workflows™ and supported automation tools.

Smooth read preparation

Automate prior-image retrieval and study preparation for interpretation.

Efficient interpretation

Review studies with guided MIM Workflows and supported automation tools.

global-impact-promo-dynamic-1920x600-img
Global impact

Wherever you are, MIM is nearby

3,300+ healthcare organizations worldwide use MIM—including 90% of the world's top 50 hospitals. Hospitals, cancer and imaging centers, research institutions and pharmaceutical companies rely on 20+ years of medical imaging innovation. 
JB04078XU November 2026

Have a question? We would love to hear from you.

Contact us

We're ready to support you in your moments that matter.

We're sorry, a problem occurred with the form. Please try again.
Thank you for your inquiry

We will be in touch soon.

Something went wrong

We will check and get back.